medline.ch Onkologie Respirationstrakt

	When to assess responses to treatments in adaptive interventions? An experimental analysis of assessment timing in a smoking cessation treatment in the context of lung cancer screening. Nicotine Tob Res Horii RI, Rothman AJ, Vock DM, Joseph AM, Branson M, Melzer AC, Begnaud A, Fu SS. PMID: 41626753 [PubMed - as supplied by publisher]
	Four New Perforane-Type Sesquiterpenes from Laurencia obtusa (Hudson) J.V. Lamouroux as Potent Lung Cancer Inhibitors: Isolation, Structure Elucidation, Cytotoxicity, Molecular Docking, Dynamics, and ADME Studies. ACS Omega Demirk, , Elçi Y, Co, Alim Toraman GÖ, Erol E, Okudan E, Topçu G. PMID: 41626507 [PubMed]
	Projecting future mortality risk of pleural mesothelioma in Italy (2020-2034): Bayesian age-period-cohort analysis over 40â€¯years of death registration. Front Public Health Sartore A, Stoppa G, Minelli G, Mensi C, Consonni D, Manno V, Marinaccio A, Fazzo L, Biggeri A, Catelan D. PMID: 41626351 [PubMed - indexed for MEDLINE]
	Radiomics-based optimization of target selection in CT-guided percutaneous lung cancer biopsy: a retrospective study. Front Oncol Wang J, Zhang Z, Liu X, Wang X, Chen Y, Liu J. PMID: 41626154 [PubMed]
	Traditional Chinese medicine for non-small cell lung carcinoma: An evidence mapping. Integr Med Res Dai Z, Chen X, Li N, Tan C, Zhang Y, Wang Y, Zhao R, Li K, Clarke M, Liu L, Chen L. PMID: 41626135 [PubMed]
	Effect of preoperative inspiratory muscle training combined with education course on postoperative pulmonary complications in high-risk patients with lung cancer after video-assisted thoracoscopic surgery: a randomized controlled trial. Contemp Clin Trials Commun Lu T, Shi Z, Huang S, Lv L, Chen X, Ma K, Li X, Lai F, Ni J. PMID: 41626065 [PubMed]
	Patient-reported outcomes with a personalized follow-up program after lung cancer resection: A single-center randomized controlled trial. Asia Pac J Oncol Nurs Luo Y, Cheng Y, Song Z, Chen H, Bo Y, Shixing H. PMID: 41625083 [PubMed]
	Lung cancer immunotherapy in 2025: where we stand and what comes next? Front Immunol Han J, Yang Z, Zhao H. PMID: 41624891 [PubMed - indexed for MEDLINE]
	Multi-omics integration and machine learning identify NPC2 as a prognostic and treatment-responsive regulator in lung adenocarcinoma. Front Immunol Li A, Cui P, Liu L, Liu J, Zhou X, Wu W, Yan Z, Guan Y, Zhang H. PMID: 41624864 [PubMed - indexed for MEDLINE]
	The needs and expectations of people eligible for lung cancer screening in Switzerland: A mixed method study. Prev Med Rep Schindler M, Schneider C, von Garnier C, Bongard C, Bulliard JL, Pozzessere C, Selby K, Akre C. PMID: 41624810 [PubMed]
	Incidence of second primary cancers in lung cancer survivors by oncological treatment: a nationwide prospective cohort study in Spain. Lancet Reg Health Eur Provencio M, Cobo M, Rodriguez-Abreu D, Carcereny E, López Castro R, Fernández Bruno M, Bernabé R, Bosch-Barrera J, Massutí B, Sánchez A, Ortega AL, Guirado M, Del Barco E, Camps C, Lázaro-Quintela M, Dómine M, Sala MÁ, Medina K, González-Larriba JL, Aparisi F, Oramas J, Aguiar D, Cerezo S, Losada B, Ruano-Ravina A, Cantero A, Ospina-Serrano AV, Calvo V, Spanish Lung Cancer Group (SLCG/GECP)b, Spanish Lung Cancer Group (SLCG/GECP). PMID: 41624086 [PubMed]
	Disentangling Links Between Lung Cancer and Infectious Pneumonia via Real-World Data and Integrative Genomics. Hum Mutat Diao YF, Chen Z, Tang YF, Xie T, Ge QY, Xie K, Cong ZZ, Shen Y, Chen S. PMID: 41624060 [PubMed - indexed for MEDLINE]
	Hepatotoxicity of new-generation ALK inhibitors versus crizotinib in patients with non-small cell lung cancer: A systematic review and meta-analysis. iScience Luo X, Du X, Chen Q, Wang C, Li L, He X, Gong Y, Chen J, Zhong X, Liu Y, Zhang X, Huang L. PMID: 41623453 [PubMed]
	Open-Label Randomized Controlled Study of a Disposable Dry Seal Chest Drainage System for Safety and Efficiency in Lobectomy Patients. Thorac Cancer Liu L, Gao X, Zhang J, Guo C, Chen Y, Huang C, Qian Z, Guo Y, Zhang Y, Li S. PMID: 41622760 [PubMed - indexed for MEDLINE]
	Machine learning-based prognostic model for local control prediction in lung cancer patients undergoing stereotactic body radiation therapy: a preliminary study. Eur J Med Res Huang BT, Lin PX, Wang Y, Luo LM. PMID: 41622255 [PubMed - as supplied by publisher]
	Multi-omics integration in deciphering non-small cell lung cancer drug resistance: current status, challenges, and future prospects. Hereditas Miao J, Guan W, Wang J, Gong H, Xie Q, Gao Y. PMID: 41622239 [PubMed - indexed for MEDLINE]
	Pulmonary origin and risk assessment of cancer-associated thrombosis. Thromb J Sun H, Zhai Q, Xin B, Zhong L, Shi K. PMID: 41622206 [PubMed - as supplied by publisher]
	Therapeutic Impact of Third-generation Tyrosine Kinase Inhibitors on Lung Squamous Cell Carcinoma with Epidermal Growth Factor Receptor Mutations: A Case Description and Systematic Literature Review. Intern Med Minematsu N, Imai Y, Hirano T, Kakimoto T. PMID: 41621872 [PubMed - as supplied by publisher]
	Bilateral Neck Dissection Effectively Improves Prognosis of Patients With T3N0M0 Glottic Carcinoma. Cancer Med Huang B, Li Y, Fang R, Lv K, Wang Z, Zhu X, Chen L, Lei W. PMID: 41621830 [PubMed - indexed for MEDLINE]
	Patient-Reported Outcomes with Consolidation Durvalumab Versus Placebo Following Concurrent Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer: Results from the Phase 3 ADRIATIC Trial. J Thorac Oncol Novello S, Cheng Y, Spigel D, Fang J, Chen Y, Zenke Y, Lee KH, Navarro A, Buchmeier E, Wen-Cheng Chang J, Shiraishi Y, Özgüro, Kim YJ, Thai Hoa NT, Hashemi SMS, Chiang AC, Turner R, Mann H, Olivo Y, Jiang H, Senan S. PMID: 41621752 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 156022

Seite 1 von 7802

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung